News Daily News Two ‘Evidence-Based Pathways’ for Stable Angina: ORBITA-2 Editorial Michael O'Riordan December 27, 2023
News Conference News TCT 2023 Ultrathin Stent Holds Its Own in High-Bleeding-Risk Patients: COMPARE 60/80 Michael O'Riordan November 01, 2023
News Conference News TCT 2023 PARTHENOPE Adds to Polymer-Free Stent Data, But Raises ST Questions L.A. McKeown October 31, 2023
News Conference News TCT 2023 BIOSTEMI: Degradable-Polymer, Ultrathin-Strut DES Shows No Late Catch-up at 5 Years Caitlin E. Cox October 27, 2023
News Conference News TCT 2023 In ACS, Ticagrelor Only After < 1 Month DAPT Beats Continuing Aspirin: T-PASS Yael L. Maxwell October 25, 2023
News Conference News TCT 2023 Comparing DCBs in De Novo CAD: Drugs, Design Matter Caitlin E. Cox October 25, 2023
News Conference News TCT 2023 ‘Light at the End of the Tunnel’ for In-Stent Restenosis: AGENT IDE Wins Big Todd Neale October 25, 2023
News Conference News SCAI 2023 SPIRIT 48: Long DES for Diffuse CAD Highly Deliverable, Safe at 1 Year L.A. McKeown May 31, 2023
News Conference News SCAI 2023 Repeat Revascularization Not Increased With Solo Ticagrelor: TWILIGHT Analysis L.A. McKeown May 22, 2023
News Conference News EuroPCR 2023 ‘Fascinating’ Unlocking Coronary Stent Prompts Cautious Praise Michael O'Riordan May 18, 2023
News Conference News EuroPCR 2023 BASILICA, Chimney Stenting: No Clear Winner to Prevent TAVI Coronary Obstruction Michael O'Riordan May 16, 2023
News Conference News ACC 2023 Short DAPT Noninferior to 1 Year After Ultrathin DES PCI: HOST-IDEA Yael L. Maxwell March 09, 2023
News Conference News ACC 2023 No Downside to Immediate Complete Revascularization in ACS: BIOVASC Michael O'Riordan March 06, 2023
News Daily News Long-term Data Support Paclitaxel-Coated Balloons for In-Stent Restenosis Michael O'Riordan February 24, 2023
News Daily News Intravascular Imaging to Inform PCI Should Be Routine: ACC Interventional Council Yael L. Maxwell February 13, 2023
News Daily News REVIVE Injects Fresh Data Into Surgery vs Stenting Controversy for PAD L.A. McKeown January 24, 2023